Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and Sufentanil for Post-Caesarean Analgesia
NCT02741219Phase 4Completed
- Sponsor
- Obstetrics and Gynecology Hospital of Fudan University
- Start
- Nov 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in postoperative pain, sponsored by Obstetrics and Gynecology Hospital of Fudan University. Primary endpoint: Sufentanil consumption at 24 hours. Started Nov 2015; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02741219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02741219.